Atlas Trials

A Randomized Study Comparing Lamivudine Versus Adefovir Dipivoxil for Prevention of zHBV Reactivation in HBsAg Seropositive Patients Undergoing Cytotoxic Chemotherapy

Clinical trial NCT00489151 · UNKNOWN

Trial details

NCT number
NCT00489151
Sponsor
Hospital Authority, Hong Kong
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Hepatitis B
Start date
2005-06-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.